CyberArk and SentinelOne team on endpoint and identity security
CyberArk (CYBR) announced a new integration with SentinelOne (S) AI-powered cybersecurity platform, SentinelOne Singularity, to protect against ...
RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
Cyber agencies share security guidance for network edge devices
Five Eyes cybersecurity agencies in the UK, Australia, Canada, New Zealand, and the U.S. have issued guidance urging makers of network edge devices and appliances to improve forensic visibility to ...
RedHill Biopharma Ltd.: RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer
The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...
BizTech9h
How To Safeguard Connected Power Devices From Cyberthreats
The convergence of IT, operational technology and the Internet of Things makes it harder to protect power systems.